Korsakoff's syndrome: A critical review by Arts, N.J.M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/179660
 
 
 
Please be advised that this information was generated on 2018-07-08 and may be subject to
change.
© 2017 Arts et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php  
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Neuropsychiatric Disease and Treatment 2017:13 2875–2890
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
2875
R e v i e w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/NDT.S130078
Korsakoff ’s syndrome: a critical review
Nicolaas JM Arts1,2
Serge Jw walvoort1
Roy PC Kessels1,3,4
1Centre of excellence for Korsakoff 
and Alcohol-Related Cognitive 
Disorders, vincent van Gogh 
institute for Psychiatry, venray, 
2Neuropsychiatry Center Thalamus, 
institution for integrated Mental 
Health Care Pro Persona, wolfheze, 
3Department of Neuropsychology and 
Rehabilitation Psychology, Donders 
institute for Brain, Cognition and 
Behaviour, Radboud University, 
4Department of Medical Psychology, 
Radboud University Medical Center, 
Nijmegen, the Netherlands
Abstract: In this review, we present a survey on Korsakoff’s syndrome (KS), a residual syndrome 
in patients who suffered from a Wernicke encephalopathy (WE) that is predominantly character-
ized by global amnesia, and in more severe cases also by cognitive and behavioral dysfunction. 
We describe the history of KS and its definition, its epidemiology, and the lack of consensus 
criteria for its diagnosis. The cognitive and behavioral symptoms of KS, which include antero-
grade and retrograde amnesia, executive dysfunction, confabulation, apathy, as well as affective 
and social-cognitive impairments, are discussed. Moreover, recent insights into the underlying 
neurocognitive mechanisms of these symptoms are presented. In addition, the evidence so far on 
the etiology of KS is examined, highlighting the role of thiamine and alcohol and discussing the 
continuity hypothesis. Furthermore, the neuropathology of KS is reviewed, focusing on abnormali-
ties in the diencephalon, including the mammillary bodies and thalamic nuclei. Pharmacological 
treatment options and nonpharmacological interventions, such as those based on cognitive reha-
bilitation, are discussed. Our review shows that thiamine deficiency (TD) is a crucial factor in the 
etiology of KS. Although alcohol abuse is by far the most important context in which TD occurs, 
there is no convincing evidence for an essential contribution of ethanol neurotoxicity (EN) to 
the development of WE or to the progression of WE to KS. Future research on the postmortem 
histopathological analysis of brain tissues of KS patients is crucial for the advancement of our 
knowledge of KS, especially for associating its symptoms with lesions in various thalamic nuclei. 
A necessary requirement for the advancement of studies on KS is the broad acceptance of a 
comprehensive definition and definite diagnostic criteria. Therefore, in this review, we propose 
such a definition of KS and draft outlines for prospective diagnostic criteria.
Keywords: Korsakoff’s syndrome, alcohol amnestic disorder, Wernicke encephalopathy, 
thiamine deficiency, ethanol neurotoxicity, thalamus, memory, executive function, history
Introduction
Korsakoff’s syndrome (KS) is a residual syndrome in patients who suffered from a 
Wernicke encephalopathy (WE), but did not receive immediate and adequate treat-
ment with thiamine replacement therapy. The most conspicuous symptom of KS is 
global amnesia, which can be very profound. In combination with other cognitive 
and behavioral deficits, usually present in more severe forms of KS, this may have 
far-reaching effects on daily life.1–3 Studies that have examined the extent, pattern, and 
nature of the anterograde episodic memory deficits in KS have contributed greatly to 
the delineation of concepts regarding human memory formation and to the realiza-
tion that memory is not a unitary function. Moreover, the study of KS has brought 
to the fore that diencephalic structures play a critical role in memory function, thus 
stimulating the search for separate and distinctive brain structures and neural circuits 
underlying the component mnemonic processes.4,5
The neuropsychological sequelae of KS have been studied since the nineteenth 
century, leading to an increasing refinement of our comprehension of both amnesia 
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and executive dysfunction.1 However, affective and volitional 
disorders, although reported in KS from the onset,6–9 have 
rarely been studied. Moreover, papers on the histopatho-
logical lesions underlying KS have not been published since 
2000, notwithstanding the fact that several of the most fun-
damental and intriguing problems involved have not been 
resolved adequately.10–12
There is no generally accepted definition of KS, and 
there are no generally accepted criteria for the diagnosis 
of KS.13 DSM-5 classifies KS as “alcohol-induced major 
neurocognitive disorder, amnestic confabulatory type.”14 
This classification is misleading, as KS in itself is not alcohol-
induced. Moreover, this classification does not allow for a 
diagnosis or classification of KS in non-alcoholic patients and 
obscures the close relationship of KS with WE. In ICD-10, 
both alcoholic and non-alcoholic KS are classified, but in 
different groups.15 Non-alcoholic KS is classified as an 
organic mental disorder (F04) and alcoholic KS as a mental 
disorder due to substance abuse (F10.26), complicating the 
use of these ICD-10 criteria. One of the aims of this paper, 
therefore, was to propose a comprehensive definition of KS 
and draft outlines for prospective diagnostic criteria.
History
KS is named after the Russian neuropsychiatrist Sergei 
Korsakoff, although the first detailed description of the 
syndrome was probably in a paper by Robert Lawson in 
1878.16 However, Korsakoff was the first to provide a com-
prehensive account of the syndrome in a series of papers 
published between 1887 and 1891.6–8,17 He observed that 
the syndrome was usually associated with peripheral nerve 
inflammation (alcoholic polyneuritis; first described by 
Moeli in 188418) and presumed that it resulted from a toxin. 
Therefore, he called the syndrome “polyneuritic psychosis 
or cerebropathia psychica toxaemica.” In 1897, the German 
psychiatrist Friedrich Jolly proposed that the syndrome 
was better named “Korsakoff’s symptom complex” or 
“Korsakoff’s syndrome.”19
A few years before Korsakoff published his first papers 
on the syndrome, the German psychiatrist Carl Wernicke 
described “polioencephalitis superior haemorrhagica” in the 
second volume of his Lehrbuch der Gehirnkrankheiten.9 
In this classical description of what was later named 
“Wernicke encephalopathy,” he characterized the disease 
by the fairly distinctive triad of eye movement disturbances, 
ataxia, and mental confusion. We have known since the 1960s 
that in most cases of histopathologically confirmed WE, 
only an uncharacteristic mental confusion occurs and that 
the clinical diagnosis of WE can be challenging and may be 
missed – in some studies even in the majority of cases.20–22 
Although the new operational criteria for the clinical diagno-
sis of WE, established by Caine et al23 (henceforth referred to 
as the “Caine criteria”; see Table 1), may lead to a remarkable 
improvement of the clinical diagnosis,23–25 the diagnosis of 
WE is in essence a histopathological one.20,21,26
The German neuropsychiatrist Karl Bonhoeffer was 
probably the first to realize that WE and KS belong together. 
He observed that all cases who survived the WE phase 
developed KS as a residual syndrome.27,28 Jolly observed 
that a similar disorder of memory could also be observed 
in patients with “senile dementia” and other diseases.19,29 
Consistent with these findings, Bonhoeffer proposed to dis-
tinguish henceforth between “Korsakoff’s psychosis” (after 
WE; what is now called KS) and “Korsakoff’s syndrome” 
(in dementia and other diseases). Soon both labels were 
used interchangeably. In the modern literature, they are used 
as synonyms, although the use of “Korsakoff’s psychosis” 
as a label is fading.
Korsakoff, Wernicke, and Bonhoeffer knew nothing 
about the real cause of WE and KS. Only after the concept 
of “vital amines” or “vitamins” had evolved (in 1912), and 
thiamine was isolated (in 1926) and synthesized (in 1936), the 
Table 1 The operational criteria for the clinical diagnosis of we, 
as formulated by Caine et al23 
Symptom 
or sign
As evidenced by one or more of the 
following
Dietary 
deficiencies
– Undernutrition (body mass index ,2 SD 
below normal)
– A history of grossly impaired dietary intake
– An abnormal thiamine status
Oculomotor 
abnormalities
– Ophthalmoplegia
– Nystagmus
– Gaze palsy
Cerebellar 
dysfunction
– Unsteadiness or ataxia
– Abnormalities of past pointing
– Dysdiadokokinesia
– impaired heel-shin testing
either an altered 
mental state 
or 
Mild memory 
impairment
–	 Disorientation	in	two	of	three	fields
– Confused
– An abnormal digit span
– Comatose
or
– Failure to remember two or more words in 
the four-item memory test
– impairment on more elaborate 
neuropsychological tests of memory function
Notes: when two out of these four criteria apply, the clinical diagnosis of we is made. 
The criteria are less sensitive in case of a co-occurring hepatic encephalopathy.
Abbreviation: we, wernicke encephalopathy.
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etiology of WE and KS could be fully clarified (in 1952).29,30 
This knowledge eventually led to a highly effective therapy 
of WE: thiamine replacement. Although synthetic thiamine 
had been available for medical use in the 1940s,29 and proof 
for the therapeutic effectiveness of thiamine replacement 
therapy was delivered in 1952, it was not until 1966 that a 
clear recommendation for thiamine replacement therapy in 
WE was made.31 This therapy increased the survival of WE 
patients immensely and created a much larger population of 
chronic KS patients than was known previously.
Definition, diagnosis, and 
epidemiology
There is no generally accepted definition of KS in the 
literature, and the implicitly accepted conceptions have 
changed over time. This has caused many problems that 
have never been debated or properly investigated. In the 
older literature, all definitions of the syndrome are purely 
cross-sectional in nature, without any requirement regarding 
its duration. The definition of Victor et al is a clear example: 
KS is 
[…] an abnormal mental state in which memory and learn-
ing are affected out of all proportion to other cognitive func-
tions in an otherwise alert and responsive patient.16,32
It is still cited in modern reviews,2,12,33 probably because it 
captures the distinguishing characteristics of KS very well. 
Recently, Kopelman et al slightly but importantly amended 
this definition by adding “resulting from nutritional deple-
tion, ie, thiamine deficiency.”2 However, the absence of 
any criterion with regard to duration or reversibility in this 
definition had important consequences, not often recog-
nized today. Victor et al diagnosed KS in any patient with 
memory problems, after the acute WE phase with confusion 
had subsided, regardless whether these were irreversible or 
transient. Patients would even receive this diagnosis when the 
memory disorder recovered completely within a few weeks 
(in one case even within 9 days).16,32 Nowadays, these quickly 
resolving memory disorders would probably be interpreted 
as part of the recovery phase of WE or as a comorbid and 
quickly remitting instance of alcoholic encephalopathy (AE). 
In order to receive the diagnosis of KS today, the memory 
disorder should be irreversible;34 in typical cases, only 
minor improvement may occur.35 Although the definition of 
Victor et al has survived, the concept of KS has changed, 
which should lead to a precautious use of the results of 
older studies. Another shortcoming of the older definitions 
is that the focus lies entirely on the severe memory disorder, 
while KS is a syndrome with many cognitive and behavioral 
symptoms.
The current inability to separate the consequences of 
thiamine deficiency (TD) from those of ethanol neurotoxicity 
(EN) is not due to some insurmountable obstacle. Nonethe-
less, it has led to hybrid diagnoses and umbrella terms like 
“alcohol-related dementia”36–38 or “alcohol-related brain 
injury.”39 These current “alcohol-related” concepts and diag-
noses hamper the clinical diagnosis of KS and complicate 
its scientific study. We would like to argue that there are no 
valid reasons why a reliable definition and reliable diagnostic 
criteria for KS would be harder to devise than definitions or 
criteria for, say, Alzheimer’s disease (AD). Clinically, the 
diagnosis of AD is not easier to make than a KS diagnosis. 
In both, memory disorders are variously accompanied by 
other cognitive and behavioral problems. Neuropathologi-
cally though, WE is easier to diagnose than AD. Intricate 
problems, like differentiating AD from normal aging and 
discerning AD among other comorbidities contributing to 
dementia, such as dementia with Lewy bodies or vascular 
dementia, have never stopped both researchers and clinicians 
in the field from studying Alzheimer-specific biomarkers and 
defining disease-specific clinical criteria.40
A comprehensive definition of KS and reliable and 
valid diagnostic criteria for KS can be formulated based 
on the evidence collected in the past few decades. A useful 
definition of KS might have the following phrasing: “KS is 
a largely irreversible residual syndrome, caused by severe 
thiamine deficiency and occurring after incomplete recovery 
from a Wernicke encephalopathy, predominantly in the 
context of alcohol abuse and malnutrition, characterized 
by an abnormal mental state in which episodic memory is 
affected out of all proportion to other cognitive functions 
in an otherwise alert and responsive patient, whose psycho-
logical make-up may be further distinguished by executive 
dysfunction, flattened affect, apathy, lack of illness insight, 
and possibly by fantastic confabulations in the early stage.” 
In milder forms of KS, especially in non-alcoholic KS, 
executive dysfunction and other cognitive or behavioral 
disorders (apart from amnesia) may be absent.41,42 Therefore, 
it is premature to require the presence of these symptoms in 
all instances of KS as long as there is no consensus on the 
severity and duration of the memory disorder required for 
the diagnosis of KS.
Diagnostic criteria for KS should be modeled in analogy 
with the other research criteria (eg, the research criteria43 or the 
IWG-2 criteria44 for the diagnosis of AD). Therefore, future 
KS criteria should include 1) a description of the specific 
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clinical phenotype of KS (for instance, a modified version 
of the here-proposed definition of KS), ideally including the 
requirement for a minimal severity of memory dysfunction, 
expressed in evidence-based cutoff scores for memory tests 
(such as the California Verbal Learning Test or the River-
mead Behavioral Memory Test); 2) in vivo evidence for WE 
pathology, either clinical (eg, the operational criteria by Caine 
et al;23 Table 1), neuroradiological (ie, using MRI; see also 
“Neuroimaging” section), or in lab reports (very low serum 
thiamine); and 3) a set of exclusion criteria. These diagnostic 
criteria would mean an immense improvement in the diagno-
sis of KS and a huge stimulus for scientific research.
Little is known about the current incidence and prevalence 
of KS. In 1987, Blansjaar conducted a survey on the preva-
lence of KS in The Hague, the Netherlands. He then found a 
prevalence of 4.8 per 10,000 inhabitants.45 Based on admission 
data in the Province of North-Holland in the Netherlands, 
Schnabel found a lower prevalence rate of about 3 patients per 
10,000 inhabitants in 1992.45 Ramayya and Jauhar46 reported 
an annual incidence of KS of around 0.5 per 10,000 between 
1990 and 1995 in Glasgow, Scotland. They cited six older 
studies, which found annual incidence rates between 0.01 and 
0.65 per 10,000. Studies on the incidence of KS in other parts 
of the world are to our knowledge lacking altogether.
Etiology and pathogenesis
Though it has been doubted by some authors,16,47 KS is 
probably always preceded by WE.26 The uncertainty that 
has arisen over this issue can be explained by the fact that 
the clinical diagnosis of WE is very difficult and therefore 
often missed.20–22
wernicke encephalopathy
In essence, the diagnosis of WE is a histopathological diag-
nosis, made after a postmortem examination of the brain.20–22 
Although the incidence has always been highest in under-
nourished alcoholics, WE has also been described in patients 
with hyperemesis gravidarum, starvation, and all kinds of 
gastrointestinal diseases, more recently also in AIDS and 
after bariatric surgery.25,48–51
WE can be treated effectively by the intravenous or intra-
muscular infusion of large quantities of thiamine.52 When this 
is done promptly, that is, within hours after the development 
of the encephalopathy, a full recovery is likely to occur. 
Even after a few days have elapsed, a complete recovery is 
still possible after thiamine replacement. When treatment is 
further delayed, however, the patient may die or recover only 
partially, with KS and nutritional cerebellar degeneration 
(NCD) as the most conspicuous residual syndromes.33,53 
Consistent with this incomplete recovery, KS patients 
show permanent damage to several structures around 
the third and fourth ventricles of the brain, especially in 
the diencephalon,51 while NCD patients show permanent 
damage in the cerebellum, especially in the vermis.53,54
KS and NCD are the most conspicuous residual syn-
dromes following the acute WE phase, but there are almost 
certainly more residual conditions or syndromes. In the most 
recent series of histopathological studies on WE and KS, all 
arising from the New South Wales Tissue Resource Centre 
(NSWTRC; Table 2), all authors describe a subgroup of 
patients with a residual syndrome that is characterized by 
irreversible histopathological damage to several structures 
(the mammillary bodies, the thalamus, and other dienceph-
alic structures) and with residual cognitive dysfunctions 
(especially executive and visuoconstructive dysfunction), but 
without damage to the anterior thalamic nuclei and without 
severe memory dysfunction, and thus without KS.26,54–61 
Keeping in mind that an irreversible, severe amnesia is 
required for the diagnosis of KS,34 this subgroup with less 
severe histopathological damage and less severe cognitive 
dysfunctions deserves in-depth scientific study. Patients with 
these hitherto neglected residual syndromes following WE 
may have contaminated control groups of “uncomplicated” 
alcoholics in studies on cognitive dysfunction in KS and 
Table 2 Neuronal numbers found in selected structures through 
detailed quantitative histopathological analyses, performed by 
researchers from the NSwTRC 
Measurement N AE AE + WE AE + WE + KS
Cortical neurons 
(superior frontal)55
100 77 80 84
Cortical neurons 
(dendritic arbor)56 
100 81 75 70
Hippocampal neurons55 100 100 100 100
Thalamus (mediodorsal)57 100 100 52 36
Thalamus (anterior)57 100 100 86 47
Mamillary bodies57 100 98 53 32
Basal forebrain58 100 100 76 79
Locus ceruleus59 100 100 100 100
Median raphe60 100 95 30 30
Dorsal raphe61 100 98 36 36
Cerebellar vermis 
(purkinje cells)54
100 95 57 57
Notes: Percentages indicate variance from control data. A change of color (from 
left	 to	 right)	 indicates	 a	 statistically	 significant	 difference.	 Reprinted	 from	 Prog 
Neuro-Psychopharmacology Biol Psychiatry, 2003;27(6), Harper C, Dixon G, Sheedy 
D, Garrick T. Neuropathological alterations in alcoholic brains. Studies arising from 
the New South wales Tissue Resource Centre. 951–961. Copyright © 2003, with 
permission from elsevier.26
Abbreviations: N, normal controls; Ae, alcoholic encephalopathy; we, wernicke 
encephalopathy; KS, Korsakoff’s syndrome; NSwTRC, New South wales Tissue 
Resource Centre.
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created the illusion of irreversible residual disturbances of 
cognition due to EN in long detoxified alcoholics.24 This mis-
conception may also have led to the continuity hypothesis62–64 
(see “Dismissing the continuity hypothesis” section). Pitel 
et al assessed whether long-abstinent alcoholics with neu-
ropsychological deficits, but without KS, fulfilled one or 
more of the Caine criteria, retrospectively applied to the 
patient’s history after having reviewed the medical records.24 
They found that patients meeting zero criteria did not differ 
from healthy controls, those meeting one criterion presented 
mild-to-moderate deficits on some of the functional domains, 
and those meeting two or more criteria had the most severe 
deficits on each of the domains examined. They concluded 
that the presence of signs of WE explains, at least partially, 
the heterogeneity of alcoholism-related cognitive and motor 
deficits. In other words, the presence of neuropsychological 
deficits in long abstinent alcoholics without KS is strongly 
associated with signs of WE.
Neuropathology
Between 1892 and 2000, around 45 papers have been pub-
lished on the neuropathology of KS, resulting in a succes-
sion of discoveries, in which each further addition did not 
challenge the involvement of the structures described before. 
The increasing sophistication of histopathological research 
and the dramatically increased survival of WE and KS 
patients since the general availability of thiamine replacement 
therapy in the 1960s are probably the most important factors 
leading to the addition of new structures to the list of lesions 
involved in the occurrence of KS. The last series of papers 
on clinic-anatomical correlation based on histopathology, 
by researchers of the NSWTRC26 (see also the “Wernicke 
encephalopathy” section and Table 2) are by far the most 
sophisticated histopathological studies on KS to date.51
Still, the current state of knowledge of KS is portrayed as 
controversial or conflicting,12,65 especially with regard to the 
question whether the critical lesion for the severe memory 
disorder is to be found in the dorsomedial or in the ante-
rior thalamic nuclei. However, Harding et al, in one of the 
NSWTRC studies,57 presented clear evidence for the critical 
role of the anterior thalamic nuclei. They convincingly argued 
that earlier studies16,32 failed to detect the histopathological 
damage in the anterior thalamic nuclei, because these studies 
did not utilize unbiased stereological techniques. In their 
study, patients with severe damage to the mediodorsal 
thalamic nuclei but without damage to the anterior thal-
amic nuclei after WE did not suffer from severe memory 
impairment during life. That the anterior nuclei are the 
critical lesion site for the memory disorder in KS is widely 
supported by converging evidence from anatomical studies 
(where these nuclei are seen as part of the limbic-diencephalic 
memory circuit, like the hippocampus), animal studies, and 
studies on vascular lesions in the thalamus.66–71 In contrast, the 
mediodorsal nuclei are densely and reciprocally connected to 
the prefrontal cortex and the amygdala, and probably belong 
to the extended-amygdala system.67
Neuroimaging
In the acute phase of WE, characteristic alterations (enhanced 
signal intensity in one or more of the structures depicted in 
Figures 1 and 2 and enumerated in Table 2; see also Figure 3) 
appear in approximately half of the cases.25,72,73 Therefore, 
finding these alterations on MRI strongly supports a clinical 
diagnosis of WE,25 and when KS is suspected, their presence 
supports the clinical diagnosis (see also “Definition, diagno-
sis, and epidemiology” section).
MRI studies of alcoholic KS patients reveal that many of 
them have gray and white matter volume deficits, but also 
that these do not differ from the volume deficits observed in 
alcoholic patients without KS.74,75 The medial thalami and the 
mammillary bodies are probably more severely damaged in KS 
patients, though a consistent correlation between mammillary 



 



 


Figure 1 Memory systems in the brain. Structures that are important for procedural 
memory are depicted in red; structures that are important for emotional memory 
are depicted in yellow. The hippocampal-diencephalic memory circuit is depicted in 
green: hippocampus (1) . fornix (2; loop around the thalamus), with one branch 
(3) to the anterior thalamic nuclei (7), another (4) to the mammillary bodies . 
mammillary bodies (5) . mammillothalamic tract (6) . anterior thalamic nuclei (7); 
projections to the cingulate cortex (8) . cingulate cortex (9) . retrosplenial cortex 
(10) . parahippocampal gyrus (11). Courtesy of Peter van Domburg, © 2017. 
Department of Neurology, Zuyderland Medical Center, Sittard, The Netherlands.
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body volume and memory impairment has not been found.76 
A more pronounced atrophy of these structures in KS is not 
an unexpected finding, for these structures are notably dam-
aged in WE and KS.26 More surprising was the finding that KS 
patients show more volume loss in the genu (anterior part) of 
the corpus callosum compared to alcoholic patients without 
KS.74 Possibly, these differences reflect a higher incidence of 
undiagnosed Marchiafava–Bignami syndrome in KS, a rare 
disorder of the corpus callosum, in which a major contribution 
of nutritional deficiencies is suspected.51,77
In non-alcoholic KS patients, MRI scans do not show 
consistent gray or white matter volume reductions. In some 
of these patients, atrophy of the mammillary bodies, 
the thalamus, or the cerebellar vermis has been found. 
However, in the eleven best documented cases of non-
alcoholic KS to date, in whom both MRI and extensive 
neuropsychological assessment were performed, no marked 
atrophy in any region or structure was found.41,42 Therefore, 
we argue that in individual cases, MRI does not enable us to 
reliably diagnose KS, although an MRI with characteristic 
lesions in the acute phase of WE (Figure 3) obviously sup-
ports a subsequent diagnosis of KS.
The contribution of alcohol
There is little doubt that chronic alcohol abuse has always 
been the most important factor in creating the context in which 
WE and KS could occur. Two of the three patients originally 
described by Wernicke9 and two thirds (30/46) of the patients 
described by Korsakoff6–8 were alcoholics. In modern cohorts, 
the proportion of alcoholics among the patients developing 
WE or KS has increased to at least 90%.78,79 However, it is still 
debated whether EN is in any sense essential for the occurrence 
of WE or essential for the development of KS following WE. 
Severe alcohol abuse certainly contributes to the development 
of WE: the high calorie content of alcohol suppresses the 
feeling of hunger and favors malnutrition, the combustion of 
alcohol requires extra thiamine pyrophosphate (a co-enzyme 
in energy-bound processes), alcoholic gastroenteritis impairs 
the absorption of thiamine, alcoholic liver diseases reduces 
thiamine storage in this organ, and alcohol may impair the 
utilization of thiamine.48,52,80
Still, none of these factors are essential for the develop-
ment of WE or KS. WE develops when thiamine is below a 
critical level in gastrointestinal conditions, in cancer, in hype-
remesis gravidarum, after chemotherapeutic treatments and in 

 
 


Figure 2 Histopathological damage due to ethanol neurotoxicity (eN) and thiamine 
deficiency	(TD).	The	yellow	areas	(1)	indicate	superior	frontal	cortical	damage	due	
to eN; red and orange areas indicate damage due to TD. The red area indicates 
the damage to the anterior thalamic nuclei (3) that is probably the critical lesion for 
the memory disorder in KS. Highlighted in orange are: dorsomedial thalamic nuclei (2), 
mammillary	bodies	(4),	basal	forebrain	(5),	dorsal	and	median	raphe	nuclei	with	floor	
and	walls	of	the	3rd	and	4th	ventricles	(6),	and	the	cerebellar	vermis	(7).	This	figure	
is	based	on	Table	2,	which	is	a	summary	of	the	findings	of	the	NSWTRC.	In	addition,	
color is added to structures not investigated explicitly by the New South wales 
Tissue Resource Centre,26	 based	on	histopathological	 findings	 reported	by	other	
authors.16,20 Courtesy of Peter van Domburg, © 2017. Department of Neurology, 
Zuyderland Medical Center, Sittard, The Netherlands.
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Figure 3 Three	fluid-attenuated	inversion	recovery	(FLAIR)	images	(5	mm	thick	with	a	2.5	mm	skip)	of	a	35-year-old	man	with	schizophrenia	and	acute	nutritional	deficiency-
induced wernicke encephalopathy (we). Note the hyperintense signal in the characteristic loci for we pathology. Reproduced with permission from Sullivan & Pfefferbaum,72 
© 2008 Sullivan & Pfefferbaum, Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.
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systemic diseases such as AIDS, renal diseases, thyrotoxicosis, 
and magnesium depletion – regardless of alcohol intake. 
The incidence of WE and KS in these conditions may be as 
high as the incidence in alcohol use disorders.50
Furthermore, the evidence that EN is essential for the 
progression of WE to KS is contestable. The progression rate 
of WE to KS in alcoholic WE patients is often considered 
to be around 84%, a figure that is mentioned in most of the 
review papers.2,67,81–83 However, this figure was derived from 
the monograph of Victor et al16,32 and was not intended as an 
estimation of the general progression rate of WE to KS in 
alcoholics. It was simply a description of their cohort, which 
was probably not very representative, chiefly because they 
used clinical definitions that have become obsolete now. For 
the diagnosis of WE, they required the classical triad, resulting 
in a selection bias favoring severe cases. The diagnosis of KS, 
on the other hand, was made when there was a memory disor-
der in the (sub)acute phase, even when it disappeared quickly 
(in one case it lasted only 9 days). In a subsequent – though 
rarely cited – study, Wood et al found a progression rate of 
alcoholic WE to KS of 56%.84 Moreover, in large studies 
based on autopsy, the prevalence of WE brain pathology is 
much higher than the prevalence or incidence of KS.21,22,48 
Therefore, it is likely that the proposed progression rate of 
85% in alcoholics is an unreliably high estimation. Conversely, 
although the progression rate of WE to KS in non-alcoholic 
WE patients has been suggested to be low (#29%),85,86 later 
reviews have reported that in up to 56% of these patients, 
WE is followed by “clinically obvious memory impairment” 
(Scalzo et al,50 p 1365). This progression rate is identical to 
the one found by Wood et al in alcoholic WE patients.84
These conclusions find support from animal studies, 
where the interval between the onset of WE and start of 
thiamine replacement is a crucial factor in determining the 
severity of the ensuing residual damage and the remaining 
disturbances.67 Moreover, animal studies and well-designed 
clinical studies in humans found that the effects of EN on 
the brain are largely or completely reversible, unlike the 
effects of TD. A recent review on TD in laboratory animals 
concludes that 
[…] the interaction between ethanol and thiamine deficiency 
does not produce more behavioral or neural pathology, with 
the exception of reduction of white matter, than long-term 
thiamine deficiency alone.67
Reduction in white matter is also the main effect of EN 
in humans. This atrophy of white matter in alcoholics is 
probably the result of demyelination, a largely or completely 
reversible process.87 On CT and MRI, white matter atrophy 
gradually diminishes in alcoholics who stopped drinking and 
remain abstinent, probably as a result of remyelination.77,88 
Moreover, well-nourished and otherwise healthy alcoholics 
usually show minimal cognitive or behavioral effects of 
their chronic heavy alcohol use,89 often improve quickly 
after abstinence,90,91 and typically recover completely after 
an abstinence period of 1 or 2 years.92
There is some evidence, mostly from animal studies, that 
EN may also result in irreversible gray matter (neuronal) 
damage, but “the degree of neuronal loss in alcoholics 
without additional nutritional or metabolic pathologies is 
surprisingly subtle” (Sutherland et al,93 p 606). Moreover, 
the (favorable) outcomes of clinical studies suggest that neu-
ronal damage is not severe in humans, or can be adequately 
compensated for.92
Dismissing the continuity hypothesis
The evidence discussed in the previous two sections amount 
to a dismissal of the continuity hypothesis, both in its 
original62,63,94 and in its revised64 forms. Basically, the conti-
nuity hypothesis states that cognitive disturbances in non-KS 
alcoholics and alcoholic KS patients lie along a continuum 
of mild to moderate deficits; due to EN, there is a correlation 
between cognitive performance and drinking history. Accord-
ing to the revised continuity theory by Pitel et al,64 
[…] there is an “episodic memory continuity” between 
AL and KS and a “working memory continuity” among 
AL, KS, and alcohol dementia patients (“AL” refers to 
uncomplicated alcoholics).
However, this hypothesis holds only in specific situa-
tions. Uncomplicated alcoholics may suffer from cognitive 
disturbances, but these will diminish and even disappear 
after prolonged abstinence. Recently detoxified alcoholics 
may still suffer from cognitive disturbances, but probably 
only as long as the temporary effects of demyelination last 
and as long as re-myelination is not completed. All evidence 
indicates that memory deficits in alcoholics who did not 
suffer from TD and did not develop WE disappear within a 
few weeks. The recovery of executive and other cognitive 
disorders may require a few to several months. Moreover, 
there is no convincing evidence that EN alone may lead to 
“alcohol dementia.” So far, all patients who received this 
diagnosis eventually turned out to suffer from residual syn-
dromes after WE, from AD, from other forms of dementia, 
or from other forms of alcohol-related co-occurring brain 
damage (pellagra, traumatic brain injury, pontine or extra-
pontine myelinolysis, Marchiafava–Bignami disease, and 
hepatic encephalopathy).16,51
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It is true that a minority of purportedly “uncomplicated” 
alcoholics does not recover completely after 1 or 2 years of 
abstinence. However, the best explanation to account for irre-
versible cognitive disorders in a minority of “uncomplicated” 
alcoholics is TD. In other words, these “uncomplicated” 
alcoholics may not be uncomplicated after all.24 WE usually 
(in 50%–70%) has an unobtrusive symptomatology and 
course. Therefore, the diagnosis is missed more often than 
not.21,22 Moreover, while there is histopathological evidence 
for a continuum of irreversible TD effects in the brain, of 
which KS is only the most conspicuous and most severe 
variant,24,26,57 there is no convincing evidence for a continuum 
of irreversible EN effects.92,95 In all probability, AE is a 
temporary and (almost) completely reversible disorder.92,95 
In the minority of chronic alcoholics with residual cognitive 
disturbances after 1 or 2 years of abstinence, it is important to 
exclude mild forms of WE (up to 19%, mostly undiagnosed79), 
Marchiafava–Bignami disease, pontine or extrapontine 
myelinolysis, pellagra, traumatic brain damage, and hepatic 
encephalopathy, before these cognitive effects can be ascribed 
to EN. Exclusion of these comorbid pathologies is often very 
difficult to achieve without histopathological postmortem 
examinations, which cannot be accomplished in clinical 
studies. Therefore, to date, there is little direct evidence for 
irreversible cognitive effects caused by EN. However, we fully 
acknowledge the reality of AE, that is, of the temporary, revers-
ible (after prolonged abstinence) cognitive effects of EN.
Therefore, the continuity hypothesis amounts to little 
more than the redundant statement that the temporary effects 
of EN and the largely irreversible effects of TD often 
co-occur and may produce different combinations of cogni-
tive disturbances. These disturbances usually diminish after 
thiamine replacement and abstinence from alcohol, due to 
a small improvement of TD effects and a (nearly) complete 
recovery from EN effects, typically in the course of a few 
months. In short, the continuity hypothesis has become 
obsolete now.
Cognitive and behavioral symptoms
KS is generally known as a disorder of memory, but from the 
very first reports, it was obvious that it is a syndrome with 
many cognitive and behavioral symptoms. In addition to 
amnesia, Korsakoff,7,8 Gudden,96 and Bonhoeffer27,28 already 
listed apathy, flattened effect, and confabulations as char-
acteristic symptoms. The concept of “executive functions” 
has fully crystallized only recently,97 but Grünthal98 and Van 
der Horst99 already isolated, described, and characterized the 
symptoms in patients with KS that we would now charac-
terize as disorders of executive function. In this section, we 
present an overview of the main symptoms of KS, based on 
the most recent research.
episodic memory dysfunction
Memory dysfunction is the only symptom of KS that has been 
studied comprehensively in the past 125 years. In the earlier 
studies, investigators were puzzled by apparent contradictions 
in the memory performance of KS patients,3,100,101 but these 
contradictions could be resolved in the 1970s and 1980s, 
after the discovery of multiple memory systems that can be 
disrupted independently by pathological processes.102–104
The severe memory impairment as a core characteristic 
for KS primarily relates to declarative memory. Within this 
declarative memory domain, both episodic memory, related 
to explicitly remembered personally experienced events spe-
cific to time and place, and semantic memory, related to facts, 
are affected. In each of these subdomains, the anterograde 
memory processes are typically more severely affected than 
retrograde memory processes.1,5,105–107
A more recent development in KS studies is the theory 
that anterograde episodic memory impairment in KS is due 
primarily to a deficit in contextual memory.108–112 KS amne-
sics often encode temporal1,12,113 and spatial113–115 contextual 
information less efficiently than normal controls and con-
sequently have great difficulties in source memory.109,116,117 
Source memory is conceptualized as a core component of 
episodic recall. It allows for the reconstruction of contextual 
details characterizing the acquisition of episodic events.
In KS, anterograde amnesia is surely one of the most 
prominent symptoms, but remote memory is affected as 
well. The resulting retrograde amnesia comprises both non-
personal information – like news facts – and events from 
autobiographical memory.110,113,118,119 Remote memory loss 
in KS patients can extend back many years, even several 
decades,110,120 but early (eg, childhood) memories are rela-
tively spared. This disproportionate loss of more recent 
memories in KS and other pathologies is called a “temporal 
gradient.” This phenomenon was first described by Théodule 
Ribot (in 1881) and is since then known as Ribot’s law. 
In KS, the majority of studies have found evidence for a steep 
temporal gradient, but some have observed more uniform 
remote memory impairments across all past time periods.121 
Methodological difficulties may be a partial explanation for 
this inconsistency, but, more importantly, there were also 
differences in the kind of memory studied: non-personal 
versus autobiographical memory. Because autobiographic 
memories are difficult to assess, they are studied less often 
than non-personal memories.122 Autobiographical episodic 
memory refers to personal events that a person is able to 
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re-experience in a detailed spatial and temporal context, for 
example, remembering how you met your first love in the bar 
of the swimming pool on a warm Friday evening. In a recent 
study, Rensen et al122 showed that the temporal gradient 
extended to episodic autobiographical memory, replicating 
previous findings.2,110,119,123
Semantic memory dysfunction
Semantic memory refers to the memory of language, con-
cepts, and well-rehearsed facts (eg, “Paris is the capital of 
France”), independent of the recall of any particular episode 
or incident specific in time and place.102 Semantic memory 
is relatively preserved in KS. Unlike dementia patients, 
KS patients show near-normal performances on semantic 
memory tests.124,125 The ability to retrieve information from 
preexisting semantic memory seems to be preserved.1,3,126–128 
However, Pitel et al129 demonstrated that, compared to 
uncomplicated alcoholics, KS patients are impaired in new 
category and feature learning, which is independent of 
episodic memory. This specific impairment may therefore 
reveal a genuine deficit of semantic memory in KS. Auto-
biographical semantic memory has also been studied in KS. 
The semantic aspect refers to knowledge that is not linked to 
single events, for example, knowing that you used to swim 
on Fridays or what your home address was during childhood. 
A temporal gradient has been repeatedly demonstrated in 
semantic autobiographical memory in KS.2,110,119,122
Procedural memory
Procedural memory is the nondeclarative memory system 
underlying verbal, motor, and other cognitive skills,130 result-
ing in learning without awareness (ie, implicit learning). 
Several studies of procedural learning in KS patients showed 
preserved learning,131–136 while others reported impaired 
learning.137–141 These differences may be largely explained by 
the type of material to be acquired, complicated by the fact 
that many procedural tasks also rely on explicit memory 
and executive functions that are impaired in KS. In recent 
reviews, it is therefore concluded that patients with KS show 
maximum procedural learning potential when the task is min-
imally dependent on other cognitive domains than procedural 
learning, when feedback is given during the task, and when 
the task itself is restricted in response options.142,143
executive dysfunction
The concept of executive dysfunction did not exist before the 
1970s.97 “Executive function” is an umbrella term for planning, 
response inhibition, response generation, concept shifting, 
and working memory updating.144,145 Grünthal correctly 
observed (in 1924) that KS patients have great difficulty in 
recalling the context of memories.98 He also realized that 
confabulations could not always be explained as automatic 
or unconscious attempts to fill memory gaps. They are often 
better understood as failures in context reconstruction. He 
therefore characterized this problem as an “alignment dis-
order” (Einstellungsstörung). Van der Horst was the first 
(in 1932) to observe that KS patients have great difficulty 
in organizing their memories in the appropriate temporal 
sequence.99 They lose track of the order of events, a symptom 
that is known since 1929 as “achronogenesis.”146 Still, it took 
considerable time to realize that KS patients might also have 
severe problems in planning and task organization, possibly 
because these problems are difficult to comprehend without 
some apprehension of executive functions.147
The executive dysfunction in KS is unremitting and 
affects all executive processes, including response inhibition, 
response generation, working memory updating, planning, 
and concept shifting.147,148 Lack of illness insight is related 
to executive dysfunction. Alcoholic KS patients have been 
found to report no cognitive complaints on self-report mea-
sures of subjective cognitive problems, despite their poor 
performance on several cognitive tests.149 There is evidence 
that in non-alcoholic KS, awareness of cognitive dysfunction 
may be preserved.41,42
Confabulations
Confabulations can be defined as “false or erroneous 
memories arising involuntarily (ie, not deliberately) in the 
context of a neurological amnesia”.12 The involuntary and 
unconscious nature of confabulations is well captured in the 
colloquial description “honest lying.”150 Korsakoff devoted 
a whole paper to this symptom of KS.17 Bonhoeffer was the 
first to use the word “confabulation” [Konfabulation] in this 
context.27
Bonhoeffer already distinguished between momentary or 
embarrassment confabulation [Augenblickskonfabulation, 
Verlegenheitskonfabulation] and fantastic or productive 
confabulation [phantastische Konfabulation, produktive 
Konfabulation].27,28 Following Bonhoeffer, a distinction is 
made between provoked (or reactive, or momentary) and 
spontaneous (or fantastic) confabulations.151–153 In provoked 
confabulations, the patient confabulates in an inconsistent 
fashion. Usually these confabulations are triggered and the 
erroneous memory communicated is generally plausible. 
In the spontaneous or fantastic type, the confabulations are 
presented and elaborated without provocation. They are less 
variable than the provoked confabulations and generally have 
a grandiose content.152,154
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Kopelman,153 after reviewing many opinions on the 
phenomenology, mechanisms, and neuropathology of 
confabulation, concluded that provoked confabulations are 
probably fleeting disorders or intrusion errors, due to failing 
memory, also seen in healthy subjects when their memory 
is weak.153,155,156 Therefore, they do not necessarily imply an 
underlying pathology or a specific anatomical basis.157
The underlying mechanisms of confabulations are under 
debate, but have been linked to intrusions on memory tests,158 
temporal context confusion,159,160 both temporal context 
confusion and executive dysfunction,161,162 and poor strategic 
and memory-monitoring capacities.163,164 The spontaneous 
confabulations in KS usually disappear within weeks after 
the development of KS, but provoked confabulations can 
often be found in its chronic stage.41,158
Apathy
Apathy can be defined as “an absence of responsiveness to 
stimuli as demonstrated by a lack of self-initiated action.”165 
This is just one of the many possible definitions. Modern 
definitions are broader than those of a century ago – when 
apathy was exclusively seen as a disorder of volition – and 
comprise cognitive and affective symptoms.166,167 This prob-
ably led to an unwarranted overlap with executive dysfunc-
tion and depression.168
That apathy is a characteristic and fundamental symp-
tom of alcoholic KS has been established from the earliest 
descriptions of this syndrome.7,8,18,27,96,169 However, in modern 
studies on KS, this symptom has rarely attracted any attention 
so far. The only paper we were able to find on apathy in KS 
is that written by Talland in 1960.169 Apathy might be less 
conspicuous or even absent in non-alcoholic KS.41,42
Although modern studies on the neuropathology underly-
ing apathy in KS are lacking, all recent studies on the neuro-
pathological basis of apathy, abulia, avolition, athymhormia, 
or akinetic mutism point to the prefrontal anterior cingulate 
cortico-subortical circuit,170–173 which connects the anterior 
cingulate with the basal ganglia and the mediodorsal thalamic 
nuclei. Lesions in other cortico-subcortical circuits rarely – if 
ever – cause apathy or any other diminishment of volition.
Disorders of affect, emotion perception, 
and social cognition
From the earliest reports, alcoholic KS patients have been 
described as emotionally flat and affectively detached, but that 
is not the whole picture. In the early stages, KS patients are 
frequently irritable or euphoric, and they usually remain affec-
tively unstable throughout the rest of their lives; suspicion and 
intense emotions are easily provoked.3,7,8,27 So far, affective 
impairments have rarely been studied in KS.174–176 Elaborating 
on the fairly recent recognition of executive dysfunction in 
KS patients,147 there is a tendency to explain affective impair-
ments in KS as a consequence of a lack of reflective abilities 
rather than a primary lack of affective abilities.174,177,178 For 
instance, deficits in perspective taking, an important aspect 
of Theory of Mind, have been found to be related to execu-
tive dysfunction in KS, and not to any inability to infer the 
thoughts and feelings of others.179 Recently, this explanation 
has been challenged.176 Based on previous studies, these 
authors argue that a subtler exploration of affective abilities 
in KS suggests that they might be impaired. For instance, the 
evidence that KS patients have a serious impairment of affec-
tive prosody perception178 and facial expression recognition, 
with stronger difficulties for categories like fear, anger, and 
surprise,180 suggest that affective abilities are not unaffected 
in KS. These hypotheses are strengthened by the evidence 
that KS patients tend to overestimate the affective content 
of stimuli and show emotional overreaction or enhanced 
sensitivity in other situations.175,181
Pharmacological treatment and 
cognitive rehabilitation
As a residual syndrome after WE, KS can be seen as a form 
of acquired brain damage. After treating WE with thiamine 
replacement and after a convalescence phase, the effect of phar-
macological interventions is necessarily confined to enhancing 
the skills that remain, or to suppress symptoms that interfere 
with normal functioning. In patients with traumatic brain 
injury, there is some evidence that these interventions may be 
effective.182 In KS, however, there is no evidence of any ben-
eficial effect of pharmacological therapy. Several case studies 
and eight double-blind trials have been published, where KS 
patients were treated with clonidine, fluvoxamine, reboxetine, 
or rivastigmine. Together, these studies did not produce any 
consistent evidence for the efficacy of any of these interven-
tions.183 Therefore, we may safely conclude that, until this date, 
no effective pharmacological treatment for KS is available.
The perspectives for rehabilitation programs are more 
promising than those of pharmacological interventions. 
The traditional view that KS is a static condition that does not 
permit further recovery is obsolete and therefore gradually 
abandoned, thanks to accumulating evidence that memory 
rehabilitation is possible in KS.143,184,185 Memory compen-
sation techniques such as using agendas, memory cards, 
smartphones, and smartwatches are promising. Six studies 
on the use of traditional and digital assistive technologies 
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(reviewed in Oudman et al143) produced evidence that these 
memory compensation techniques may be helpful in KS, 
provided that 1) the formulated goals are restricted, 2) much 
time is available to guide the patient, and 3) the use of these 
technologies is holistically embedded or combined with 
elaborated learning techniques.143
Interventions based on errorless learning are probably – at 
least in theory – best suited to the cognitive abilities and dis-
abilities of KS. Its most important element is that the patient 
is not allowed to make errors during learning. All guessing is 
eliminated, in order that the patients’ procedural memory is 
not allowed to become familiar with an incorrect or unpro-
ductive strategy, which the defective episodic memory cannot 
correct or compensate for.186,187 So far, only a few studies 
have been published in which errorless learning has been 
compared to trial-and-error learning.134,188–190 The results of 
these studies are somewhat mixed, but errorless learning 
might be beneficial compared to trial-and-error learning in 
some learning situations. Moreover, the beneficial effects of 
errorless learning are not restricted to procedural learning but 
may also support semantic learning.143
Conclusion and further perspectives
In this narrative review, we summarized the current knowl-
edge on KS. It differs in important respects from other 
modern reviews on KS and WE.2,48,81–83 That is, we argue 
that the contribution of alcohol abuse to the development of 
WE and KS is limited to creating the context in which TD 
is most likely to develop and in which lengthy patients’ and 
doctors’ delay are prone to occur. Alcohol abuse is the most 
important cause of malnutrition and TD, and the living condi-
tions and socioeconomic status of alcoholics are responsible 
for extended treatment delays, thus favoring the progression 
of WE to KS. However, we have not been able to uncover 
convincing evidence for an essential contribution of EN to 
the development of WE or to the progression of WE to KS. 
The contribution of alcohol abuse to the development of WE 
and KS is massive, but seems to be circumstantial. Animal 
experiments and recent studies on the development of WE 
and KS in non-alcoholic patients have demonstrated that the 
occurrence of WE and KS can be fully explained by TD. 
Moreover, the best explanation for the progression of WE to 
KS is treatment delay. Furthermore, we concluded that there 
is little evidence to support the continuity hypothesis, neither 
in its original62,63,94 nor in its revised91 version.
The study of the complete spectrum of residual syn-
dromes after WE is only possible when KS is adequately and 
comprehensively defined and when it can be diagnosed 
reliably. Therefore, there is a clear need for a generally 
accepted definition (for which we formulated a proposal in the 
“Definition, diagnosis, and epidemiology” section) and reli-
able diagnostic criteria. Moreover, the scattered information 
about the etiology, symptoms, treatment, and course of the 
many forms of collateral brain damage in alcoholics should be 
integrated in a comprehensive “taxonomy of alcohol-related 
brain damage.” A renewed interest in postmortem histopatho-
logical analysis of brain tissue of KS patients is an important 
prerequisite for the further development of our knowledge of 
KS, especially for the functional localization or association of 
its symptoms with damage in various thalamic nuclei. With 
neuroimaging techniques, the underlying neuropathology 
of KS cannot be rendered visible in a reliable way. This is 
a major drawback, not just for our knowledge of KS. KS is 
the most constant and consistent form of thalamic pathology. 
Improved knowledge of KS may help to answer vexing ques-
tions with regard to thalamic function: 1) What are the precise 
functions of the structures that are joined in the hippocampal-
diencephalic memory circuit, such as the thalamus, mammil-
lary bodies, fornix, retrosplenial cortex, hippocampus proper, 
and parahippocampal structures?191–193 2) What is the exact 
functional specialization of the separate thalamic nuclei?194–197 
3) In which ways do the anterior and mediodorsal thalamic 
nuclei contribute to episodic memory?12,195,198–200
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